News

DEAR MISS MANNERS: I am a gentleman who strives to live a mannerly life. In that regard, when riding public transportation, I ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
The US Food and Drug Administration (FDA) has approved KalVista Pharmaceuticals' Ekterly (sebetralstat) as the first and only ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
E-bike battery malfunction leads to fire and first NYC battery-related death in 2025, trapping 76-year-old woman in a Queens pizzeria.
There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...